Friday, July 10, 2026

Drug profile · INN

phenyl aminosalicylate

phenyl aminosalicylate (PHENY-PAS-TEBAMIN) is a unknown. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — phenyl aminosalicylate
US status
approved
Class
Route
ORAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

phenyl aminosalicylate (PHENY-PAS-TEBAMIN) is a unknown. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN phenyl aminosalicylate
Brand PHENY-PAS-TEBAMIN
Mechanism Unknown
Route ORAL
Formulation POWDER

Mechanism of action

Unknown

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is phenyl aminosalicylate?

phenyl aminosalicylate (PHENY-PAS-TEBAMIN) is a unknown. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for phenyl aminosalicylate?

PHENY-PAS-TEBAMIN is a marketed brand name for phenyl aminosalicylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of phenyl aminosalicylate?

phenyl aminosalicylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.